News
September 27, 2011
White House Awards UC San Diego Bioengineering Professor Shu Chien National Medal of Science
President Barack Obama today named University of California, San Diego bioengineering professor Shu Chien one of the seven eminent researchers to receive the National Medal of Science, the highest honor bestowed by the United States government on scientists and engineers. Chien is the only engineer among the seven medalists. Full Story
September 12, 2011
UC San Diego Bioengineers Named 2012 Siebel Scholars
With the 2012 class of Siebel Scholars, 85 new scholars – including five from the UC San Diego Jacobs School of Engineering – join an ever-growing, lifelong community of leaders. Today, 700 Siebel Scholars are active in a program that fosters leadership, academic achievement, and the collaborative search for solutions to the world’s most pressing problems. Full Story
September 7, 2011
Accessible and Affordable Care at Heart of Healthcare Technology Grants
Five teams of scientists from multiple campuses of the University of California and a Southern California hospital have been awarded up to $100,000 each to commercialize their ideas for new, lower cost health care technologies that will address a long-standing need for more affordable and efficient chronic disease management and preventive health care, particularly in underserved communities. The commercialization grant program is led by the von Liebig Entrepreneurism Center at UC San Diego Jacobs School of Engineering. Full Story
September 1, 2011
Glowing, Blinking Bacteria Reveal How Cells Synchronize Biological Clocks
Biologists and bioengineers at UC San Diego created a model biological system consisting of glowing, blinking E. coli bacteria. This simple circadian system, the researchers report in the September 2 issue of Science,allowed them to study in detail how a population of cells synchronizes their biological clocks and enabled the researchers for the first time to describe this process mathematically. Full Story
August 25, 2011
Genomatica Files Registration Statement for Proposed IPO
Renewable chemicals developer Genomatica announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) of shares of its common stock. Full Story
August 10, 2011
Wearable Electronics Demonstrate Promise of Brain-Machine Interfaces
Research conducted by a new member of the bioengineering faculty at the University of California, San Diego has demonstrated that a thin flexible, skin-like device, mounted with tiny electronic components, is capable of acquiring electrical signals from the brain and skeletal muscles and potentially transmitting the information wirelessly to an external computer. The development, published Aug. 12 in the journal Science, means that in the future, patients struggling with reduced motor or brain function, or research subjects, could be monitored in their natural environment outside the lab. It also opens up a slew of previously unimaginable possibilities in the field of brain-machine interfaces well beyond biomedical applications, said Professor Todd Coleman, who joined the Department of Bioengineering at the UC San Diego Jacobs School of Engineering this summer. Full Story
July 29, 2011
UC San Diego Bioengineering Startup Genomatica Tops New Biofuels Ranking
Renewable chemicals developer Genomatica recently took the #1 spot in the 2011-12 30 Hottest Companies in Renewable Chemicals and Materials rankings by BiofuelsDigest. Full Story
July 26, 2011
New UC San Diego Master Degree Program Aims to Keep the Medical Device and Medical Diagnosis Workforce Competitive
Engineers at the University of California, San Diego are launching a new graduate degree program this fall that will help medical device and medical diagnosis engineers in Southern California, and their employers, innovate and remain competitive. Full Story
June 20, 2011
Nanoparticles Disguised as Red Blood Cells Will Deliver Cancer-Fighting Drugs
Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body’s immune system and deliver cancer-fighting drugs straight to a tumor. Their research was published this week in the online Early Edition of the Proceedings of the National Academy of Sciences. Full Story
May 31, 2011
Bioengineered Medical Devices in Finals for $100K UC San Diego Entrepreneur Challenge
From hospital-borne infections that cause nearly 20,000 deaths each year to a debilitating dry eye disease that can lead to blindness, engineering students at the University of California, San Diego are developing medical devices that promise to lower costs, improve patient care and save lives. So it’s not surprising that two student teams from the UC San Diego, Jacobs School of Engineering are in the running for $100K prize as finalists in the 5th Annual UC San Diego Entrepreneur Challenge on June 1. Full Story